Budapest, Hungary; Cambridge, MA & Richmond, VA (PRWEB) September 24, 2014 – Omixon collaborates with G3 and Genomics England to HLA genotype 340 individuals by three different methods in a bit to demonstrate equivalency among WGS approaches, best in class targeted approaches (Holotype HLA) and legacy methods (Sanger SBT).
Read the full article here:
![Omixon Collaborates with G3 and Genomics England to Validate HLA Genotyping from WGS Data](/sites/default/files/styles/half_width_image/public/2019-11/Omixon-Collaborates-with-G3-and-Genomics-England.jpg?itok=00cv2GP_)
News